[HTML][HTML] Alzheimer disease: an update on pathobiology and treatment strategies

JM Long, DM Holtzman - Cell, 2019 - cell.com
Alzheimer disease (AD) is a heterogeneous disease with a complex pathobiology. The
presence of extracellular β-amyloid deposition as neuritic plaques and intracellular …

Synaptic degeneration in Alzheimer disease

RL Buckner, J Sepulcre, T Talukdar… - Journal of …, 2009 - Soc Neuroscience
Recent evidence suggests that some brain areas act as hubs interconnecting distinct,
functionally specialized systems. These nexuses are intriguing because of their potential …

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease

JC Lambert, S Heath, G Even, D Campion, K Sleegers… - Nature …, 2009 - nature.com
The gene encoding apolipoprotein E (APOE) on chromosome 19 is the only confirmed
susceptibility locus for late-onset Alzheimer's disease. To identify other risk loci, we …

The intersection of amyloid beta and tau at synapses in Alzheimer's disease

TL Spires-Jones, BT Hyman - Neuron, 2014 - cell.com
The collapse of neural networks important for memory and cognition, including death of
neurons and degeneration of synapses, causes the debilitating dementia associated with …

Trafficking and proteolytic processing of APP

C Haass, C Kaether… - Cold Spring …, 2012 - perspectivesinmedicine.cshlp.org
Accumulations of insoluble deposits of amyloid β-peptide are major pathological hallmarks
of Alzheimer disease. Amyloid β-peptide is derived by sequential proteolytic processing from …

The role of apolipoprotein E in Alzheimer's disease

J Kim, JM Basak, DM Holtzman - Neuron, 2009 - cell.com
The ɛ4 allele of apolipoprotein E (APOE) is the major genetic risk factor for Alzheimer's
disease (AD). Although there have been numerous studies attempting to elucidate the …